330 people who took part in the survey were presented with a list of management and leadership skills. Those of the respondents who are leaders were asked to rate their confidence in applying the skills, whilst those in non-management positions were asked to rate their line manager's skills. Both sets of respondents were also asked to place the skills in priority order.
The management skills were: Setting clear tasks and objectives. Providing clear roles and responsibilities. Communicating clearly and effectively. Monitoring and evaluating. Planning and organising. Effectively managing difficult situations.
The leadership skills were: Providing rationale and explaining why. Regularly providing and seeking feedback. Building trust. Providing guidance and training. Creating development plans and opportunities.
Interestingly, the survey found a close correlation between how the leaders and the employees prioritise these things, with management skills being perceived as more important overall than leadership skills.
Communicating clearly and effectively was deemed the most important skill of all (ranked 9 out of 10 by both groups). Meanwhile, creating development plans and opportunities for others was prioritised the least (ranked 3.7/10).
But hang on a moment. If both the managers and the employees agree that creating development plans and opportunities is the least important thing, then surely it is? In other words, if employees say that creating development plans is unimportant, then surely it is unimportant, and if leaders think the same, they would appear to be right.
Maybe, maybe not. Perhaps employees don't know what's good for them, and leaders don't know what employees don't know what is good for them. If you take my point.
Veterinary leaders were then asked to rate their confidence in applying the listed leadership and management skills. The skills which elicited the largest number of 'not confident' responses were: monitoring and evaluating performance, regularly providing and seeking feedback, and creating development plans and opportunities for others.
The skills with which leaders were most confident were: communicating clearly and effectively, building trust, and providing rationale and explaining why.
Again, there was a close correlation between prioritisation of these skills and confidence levels.
VMG Vice President Richard Casey said: “The survey has helped us to identify priorities for learning and development both at our 2020 Congress and during our joint CPD programme next year. It is striking that the very skills required to motivate colleagues to remain in veterinary medicine and to support them in doing so are the ones which so many veterinary leaders admit that they lack confidence. Given the challenges the profession faces, it is also concerning that they appear to be undervalued both by veterinary leaders and the team members who report to them.
"Delegates to SPVS-VMG Congress and our other 2020 CPD events will benefit from a wealth of evidence-based lectures from experts on all aspects of veterinary leadership and management, enabling them to improve their own performance and contribute to an overall raising of standards of leadership and management across the veterinary sector."
Peter Brown, Senior Vice-President of SPVS, said: "We know that veterinary students receive an excellent clinical training and, in recent years, universities have started to include more non-clinical skills on the curriculum. However, these results suggest that when professionals move into more senior roles, be it leading a team or running their own practice, they find they still need to acquire new skills. SPVS’ role has always been to equip veterinary professionals to be effective leaders and SPVS-VMG congress is an excellent opportunity to both hear inspiring speakers and meet and learn from fellow leaders within the profession."
The VMG-SPVS 2020 joint Congress takes place from 23-25 January at the Celtic Manor Resort, Newport, and will feature dedicated streams on effective leadership, management mastery, practice profitability, preparing for a digital future and sustainability in practice.
Details on the VMG-SPVS 2020 CPD Programme can be found here: https://spvs-vmg-events.co.uk/cpd-events/
The researchers, from the Dick Vet Equine Hospital, University of Edinburgh, Newcastle University, Istituto Zooprofilattico Sperimentale delle Venezie, and the University of Padova found that affected horses have major abnormalities in the structure of their neuromuscular junctions, microscopic sites of communication between nerves and muscles that are crucial for normal muscle function.
These abnormalities are believed to represent a toxin specific signature, effectively a ‘smoking gun’, for a neurotoxic enzyme termed a phospholipase A2.
Work is now underway to definitively identify the source of the toxin, in the hope that it will lead to novel treatments and improved diagnostics for this devastating disease.
The researchers think the toxin is likely to be produced by a microbe such as a bacterium or fungus growing on the horse’s pasture during the cold and dry weather which commonly precedes the disease.
Neurotoxic phospholipase A2 toxins are also present in the venom of many poisonous snakes, and there are many similarities between the signs of grass sickness and those of snake envenomation.
While there is no suggestion that venomous snakes cause grass sickness, it is hoped that some of the drugs that are currently being developed to treat and promote nerve regeneration in people paralysed by snake venoms can aid recovery of horses from grass sickness.
The researchers say that the neurotoxin most likely also causes the apparently identical diseases (termed animal dysautonomias) which affect cats, dogs, hares, rabbits, llamas, alpacas and sheep, and that their finding contradicts the previous leading hypothesis that grass sickness is a form of botulism.
This breakthrough is summarised in an editorial in the January 2025 issue of the Equine Veterinary Journal (EVJ).
The editorial, by Bruce McGorum and colleagues, looks at the implications of their article 'Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions2".
Bruce said: “Identifying a probable cause of Equine Grass Sickness represents a significant breakthrough.
"We hope that this discovery will lead to novel treatments and improved diagnostics for this devastating condition.
"We are very grateful for the generous support we have received from horse owners, veterinary surgeons, scientists, charities and funding bodies.”
Bruce's editorial is currently available on Early View, free for 12 weeks, and will also be published in the January 2025 print issue of the EVJ.
Reference
VetSurgeon.org has launched a new collaborative publishing section of the website (called a wiki) in which any member of the site may publish case studies and reports, abstracts, short communications, research papers and the results of clinical audit for open discussion and review by all.
The state-of-the-art systems in use on VetSurgeon then allow all members to comment on the work submitted. Initially, it's hoped that this will stimulate valuable further debate, discussion and critical review of papers that have already been published elsewhere. However, another benefit of this system is that it enables anyone in the profession to publish their research to the veterinary community immediately, without being at the mercy of such things as the availability of space in a traditional print journal, so original work is warmly welcomed.
Arlo Guthrie, editor of VetSurgeon said: "Of course I recognise that authors still want the kudos of publication in a traditional peer reviewed journal. However, in addition to offering immediate publication, this system also opens the review process up so that everyone in the profession can participate in a completely open way. If it works, it may even come to be thought of as a more stringent and robust method of review than the traditional method. Or perhaps more likely, peer review could become a two stage process in which work is assessed by a panel of experts and then by the sort of 'open review' offered by VetSurgeon.org."
Doubtless there will be concerns about the validity of information published in this new section of VetSurgeon, primarily because it may NOT have been subject to peer review at the time of publication. Arlo said: "I don't think this is an issue. VetSurgeon members should just have a different starting point. When you read content in, say Vet Record, you can presume it's been scrutinised and read it in that context. On VetSurgeon, you should assume the opposite, and then use the tools offered by the site to judge the value of the work yourself."
Ways of assessing work published on VetSurgeon.org include:
In phase one of this project, taking place over the coming few days, all abstracts published in Veterinary Practice magazine are being uploaded to the new wiki.
Click here to visit the new VetSurgeon Wiki
International Cat Care has launched a competition in which veterinary practice staff are invited to take a 'selfie' of themselves with their favourite cat and upload it to the International Society of Feline Medicine (ISFM) Facebook page (www.facebook.com/ISFMcats), where cat lovers from around the world can vote for their favourite.
The Cattitude competition is designed to raising awareness of the charity's global Cat Friendly Clinic initiative.
The photograph that gets the most Facebook 'likes' will be used by the charity to help raise awareness of the Cat Friendly Clinic programme, which aims to promote the wellbeing of cats visiting or being hospitalised in a veterinary practice. Accredited Cat Friendly Clinics fulfil a set of broad criteria that show they recognise the specific needs of cats and their owners, and place cat welfare high in their practice priorities. Cat owners in turn are able to seek out clinics that have taken steps to help them overcome common barriers to clinic visits and reduce the stress of their pet.
The Cattitude competition runs from now until the 24th April. The winning staff member will receive £200 worth of John Lewis vouchers and the practice £400 worth of Thames Medical vouchers to be spent on feline-friendly equipment.
Practices may upload as many photos as they like to the Facebook page, and will be able to encourage clients to 'Like' their photos with campaign support materials which include downloadable in-clinic display posters, a series of supplied posts for their own Facebook page, written copy for their own clinic newsletter or email along with a proforma press release they can send to their local newspapers and publications.
Clinics can find more information on taking part in the Cattitude competition at www.facebook.com/ISFMcats orwww.icatcare.org/cattitude. Details of the ICC Cat Friendly Clinic initiative and accreditation can be found atwww.catfriendlyclinic.org along with a list of already-accredited vet clinics.
Merial has announced the launch of Viral Cats, a national campaign designed to educate one million cat owners about the importance of vaccination.
According to PDSA research, approximately 3.9 million cats in the UK are not up to date with their vaccinations and around 2.7 million cats have never been vaccinated1.
As part of the campaign, Merial is pushing a series of animations to cat owners via Facebook, which link to the campaign website: www.viralcats.co.uk. The website offers detailed information about the importance of vaccination and interactive content including a 'risk checker' quiz.
The 'risk checker' quiz will ask owners a series of questions to find out whether their cat is up to date with its vaccinations. If not, they'll be directed to speak to their vet. If the vet recommends restarting the primary vaccination course, owners will be able to download an amnesty voucher – directing them to participating practices to get their pet back on track. For those who are up-to-date with their cat’s vaccinations, but want to help spread the word, there will be a competition and prize.
Aiz Baig, product manager at Merial, said: "This campaign is really exciting for Merial, offering us a great opportunity to reach and educate cat owners on the importance of vaccination, which of course will drive footfall into practices."
There are several ways veterinary practices can get involved with the campaign:
To find out more about the campaign, or take part, contact your regional Merial Territory Manager.
References:
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
Avacta has announced the launch of Sensitest, the only UK-specific equine allergy tests that use non-invasive procedures.
The company says that the new range of ELISA tests was developed using native plant allergen species, to reflect the needs of UK and Northern European veterinary surgeons.
Janice Hogg, Avacta senior veterinary director, said: "In the development trials, allergens were selected that showed significant levels of reactivity in horses with clinical signs compatible with allergic disease.
"Whilst many providers of allergy tests are reducing the number of allergens in their panels and providing only a global range of allergens, this research has shown it is vital to include native species of allergenic plants and insects.
"The new ELISA test, which includes allergens such as orchard grass, daisy, dandelion, nettle and horse chestnut, provides UK practitioners with a viable alternative to intradermal testing (IDT). It doesn’t require clipping and has no adverse reactions - ideal for clients who want to avoid this."
Avacta says Sensitest includes panels of allergens that cover the work up of food, respiratory and atopic allergic disease assisting in a more accurate diagnosis, treatment and management options, including allergen-specific immunotherapy.
Janice added: "It is not necessary to withdraw medications (except high dose corticosteroids) for the standardised procedure, which has excellent reproducibility and is not influenced by existing skin pathologies, all of which is really useful when working with equine clients.
"To further assist equine practitioners, especially those faced with non-insured clients, the SENSITEST Equine Screening Test offers a simple positive/negative result to each panel, allowing expansion to the full panels as required to assist with treatment."
For more information contact your Avacta area territory manager, call customer services on 0800 8494 550 or visit www.avactaanimalhealth.com/equineallergy
TwistPak bottles have a hygienic interlock at the bottom, which allows them to be connected with a twist, creating one single mixing chamber which fits in all standard vaccination devices.
Currently, freshly mixing two vaccines requires a transfer needle.
Boehringer says the TwistPak bottle simplifies the mixing process while retaining the flexibility of using the products as a monovalent or combined vaccine.
TwistPak was jointly created with the industrial design and product development company DESIGNquadrat and awarded a Red Dot Design Award 2021 in the product design category.
Eva Joras, Global Brand Manager at Boehringer Ingelheim said: “TwistPak revolutionizes how vaccines are mixed.
"The mixing platform combines the best of both worlds: the unparalleled quality and efficacy of freshly mixed vaccines with the convenience of ready-to-use solutions.
TwistPak will be globally available in all registered presentation sizes starting May this year.
The ProfCon Investigation Support (PCIS) service is a free, confidential listening and support service funded by the RCVS and its Mind Matters Initiative mental health project but delivered independently by VetSupport.me, an organisation that already offers general support services to veterinary surgeons and veterinary nurses.
The service is provided by a group of trained and experienced volunteers who will also be able to offer support to any veterinary surgeon or veterinary nurse who is acting as witness.
Lizzie Lockett, RCVS CEO, said: “At the RCVS we recognise that being investigated in respect of alleged professional misconduct is a very stressful and trying experience that can knock confidence and, in some cases, lead to distress amongst practitioners.
“While part of the social contract of being members of regulated and protected professions is that, when accusations around professional misconduct are made, they have to be fully investigated by a regulator to determine if there is a case to answer. As a compassionate regulator we want to make sure that individuals going through this process can access the help and support they need.
“This service is staffed by a team of brilliant volunteers who already have experience in providing help and support on matters of mental health and wellbeing and have received additional training to augment their ability to provide emotional support to vets and nurses who may be under investigation.
“In our Strategic Plan for 2020-24, one of our key ambitions is to strengthen our credentials as a compassionate regulator that acts with empathy and understanding. The ProfCon Investigation Support Service is an important step in fulfilling this ambition, and I hope that it can deliver help to the people that need it.”
David McKeown, from VetSupport, added: “Whether via a phone call, an email conversation, or a meet-up over Zoom, our team of trained volunteers, all of whom are registered vets or vet nurses themselves, will support service users through the duration of an RCVS investigation.
“Through their support we will aim to help individuals going through this process maintain good mental health and wellbeing and strive to prevent more serious issues arising. The service is completely confidential and no conversations that individuals have with our volunteers will ever be shared with anyone else, including the RCVS. Nothing will be fed back to the College nor be used as part of the investigation process. It is also completely within the individual’s control as to how much information is shared with the VetSupport volunteer. There is no obligation to disclose any information other than perhaps a first name.
“We look forward to working with the RCVS to provide this very important service. Please don’t hesitate to contact us on info@vetsupport.me or visit www.vetsupport.me to find out more about the service and meet our team of supporters.”
Virbac Animal Health has launched Speed Leish K, a diagnostic test for canine leishmaniosis.
Speed Leish K detects antibodies directed against the kinesins of leishmania using a Kinesin Capture Complex (KCC), a complex of recombinant proteins with strong immunogenic power at all stages of infection. Virbac says that in trials the test has demonstrated 98.5% overall accuracy.*
Virbac Product Manager Simon Boulton MRCVS said: "Leishmaniosis presents a growing threat to UK dogs, particularly those which travel with their owners on holiday to regions where the disease is endemic.
"Speed Leish K should be used as part of the primary CaniLeish vaccination protocol in animals previously at risk of exposure to ensure only health animals are vaccinated. The test can also be used to screen for the disease in animals suspected to be infected."
Speed Leish K is presented in kits of two or six tests and can be stored for 24 months at room temperature.
Equine vets at the Animal Health Trust are appealing to horse riders to help with a research project, to assess the interaction between horse, saddle and rider.
Dr Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust and Line Greve, PhD student, are conducting the study to find out how the horse, rider and saddle can influence each other. They are trying to understand better why a saddle may persistently slip to one side in some horses.
Line said: "Saddle slip is a problem seen in all sorts of horses and ponies and can contribute to back pain and thus impaired performance. Research suggests that 25% of British dressage horses have a history of back-related problems and subsequent reduced performance. Our preliminary studies involve just over 700 riders but for a more accurate picture we would like to bump this figure up to 1000 plus. We are urging all riders, whatever their level or ability, to help by completing the questionnaire."
The online questionnaire should take no more than 15 minutes to complete and all answers remain anonymous. The questions cover saddle types, fitting, use and maintenance; rider experience, training and 'handedness'; as well as horse type, use and any previous lameness or back-related problems.
To take part in the study, complete the questionnaire here: http://www.aht.org.uk/cms-display/premise_questionnaire.html. The AHT says that by doing so, you'll be helping to protect and improve the future health, welfare and longevity of the ridden horse.
The results will be presented at the Saddle Research Trust Conference in 2014.
Bimeda has announced the launch of Bilovet, a new tylosin-based antibiotic for cattle and pigs.Padraig Hyland, Head of Technical Veterinary Services at Bimeda said: ''It is with great pleasure that I announce the launch of our much anticipated Bilovet 200 mg/ml solution for injection for cattle and pigs as the latest addition to Bimeda's range of essential antibiotics.
Bilovet contains Tylosin 200 mg/ml and is the second Tylosin-based injectable antibiotic to be licensed for cattle - including dairy cattle - in the UK. Bilovet is licensed in cattle for the treatment of respiratory infections, metritis, mastitis, interdigital necrobacillosis and calf diphtheria as well as a range of pig infections, including enzootic pneumonia, haemorrhagic enteritis, erysipelas, arthritis and metritis".
Bimeda's Head of Bimeda R+D, Xavier Molins said: "Bilovet is a completely new development for a product that includes a new species (cattle). Bimeda have made a significant investment in bringing Bilovet to market, including conducting new Environmental Risk Assessment studies according to current guidelines and regulations.''
For more information, ring 01248 725 400 or email: uksales@bimeda.com
Suffolk veterinary surgeon Gerhard Putter is appealing for support for a gala evening on 14th March 2015 to raise funds for a bucket list set up by his colleague, vet Lisa Milella, who has been diagnosed with incurable Motor Neurone Disease.
Lisa, one of the world’s few specialist animal dental surgeons, has volunteered for charity International Animal Rescue (IAR) for many years. She is also a trustee of the charity. During her time working with IAR, she has worked in countries including India and Indonesia, treating animals including abused bears, orangutans and slow lorises, which have suffered cruelty at the hands of humans. Now, as her health deteriorates, she is unable to work herself, but she is devoting her remaining time to fundraising for IAR to ensure her work can continue when she is no longer here.
Gerhard, who works at the Mulbery Court Veterinary Centre in Sudbury and is also a specialist veterinary dental surgeon, has worked with Lisa many times. He is now hosting the gala evening at Stoke by Nayland Golf Club to support her fundraising efforts. Tickets cost £25.00 per person and include a buffet, entertainment, raffle and other attractions.
He said: "Lisa helped 'dancing bears' which had had their teeth knocked out with iron bars to make them easier to control; slow lorises which had their teeth clipped off by illegal traders before being sold as pets and even orangutans, which are sometimes beaten by their captors, leaving them with broken teeth and bruises. I've seen at first-hand how important her work is and have worked with her on a number of volunteer projects.
"Her diagnosis with MND is a terrible personal tragedy for her but she is focusing on the positive and trying to do what she can for these animals while she still can. The teams at Mulberry Court and the All Animal Dental Centre are determined to support her but the success of our Gala Evening depends on the generosity of people willing to support Lisa’s Mission to raise as much money as possible.
"We hope everyone will get behind us and buy tickets. We would also welcome gifts for our raffle and any other offers of help."
For more information, please email Gerhard Putter, at Mulberry Court Vet Surgery, allanimaldentalcentre@gmail.com or contact him on 01787 881888.
The Smart Home Monitoring Kit for pets includes an indoor camera which comes with an in-built temperature sensor and night vision, a door sensor and a Smart Plug which can be remotely activated to turn on a radio, lamp, portable heater or fan to help keep animals content.
Although designed primarily for pet owners, Petplan says the kit is also being used by some veterinary practices to help provide additional security and monitoring capabilities within the practice.
The kit also contains an SD card allowing clients to share footage of their pet in the home with their veterinary surgeon when explaining behavioural symptoms. Likewise the practice will be able to record and share footage with their staff or clients.
Isabella Von Mesterhazy, Head of Marketing at Petplan, said: "For Petplan, keeping pets healthy always has been and always will be our priority. Spending time away from your pet can be hard, so the new pet Monitoring Kit addresses this problem by providing welcome peace of mind that they are safe and well. We are delighted to be able to offer Petplan veterinary practices and their staff the chance to get their hands on a Monitoring Kit at an exclusive price."
To find out more about the exclusive offer available for Petplan veterinary practices and staff until 9th December, visit petplanvet.co.uk.
The association says that the day of lectures is mainly targeted at those who are starting on their path of ophthalmology, but old hands may also learn a few new tricks.
Topics will include how to get the most from the ophthalmic examination, diagnostics and what options there are for career growth in our specialty.
There will be live panel discussions to give attendees the opportunity to ask any questions they have.
Tickets costs £100+VAT for BrAVO members, £60+VAT for nurses and interns, and £40+VAT for students.
The deadline for registration is Tuesday 16th March at 5:00pm.
To book your ticket, visit: https://www.eventbee.com/v/bravo-spring-meeting-2021/event?eid=164693974#/tickets
For the study, researchers reviewed the anonymised medical records of 2,040 chelonia on the College's VetCompass database.
94.26% were recorded as tortoises, 3.63% terrapins and 2.11% turtles.
The most common tortoise species were Hermann’s tortoise, Horsfield’s tortoise and Mediterranean spur-thighed tortoise, while the most common terrapin species were musk turtle and yellow belly slider.
The study found that the most common disorders in tortoises were beak abnormality (17.68%), overgrown nails (11.91%) and shell abnormality (9.67%), while the most common disorders in terrapins were top and bottom shell abnormalities (13.51%).
The researchers say that most of these disorders are externally visible making them easier to recognise and diagnose, however they also often correspond with inappropriate husbandry and can be related to internal diseases that are harder to identify and diagnose.
The average age of death in the study was found to be 7.32 years, which is below the expected lifespan of most species of tortoise, suggesting that many are dying prematurely.
Dr Jessica May Hornby, exotic veterinary surgeon and lead author of the study, said:
“This research has provided us with a base to start to understand what veterinarians are currently seeing in practice and therefore give an insight into the health of the chelonian population.
"People are no longer only keeping the more common species of pets, such as dogs and cats, so this data is vital to understanding where and how owners and veterinarians need further support and training to ensure these brilliant little guys get the veterinary care they need, especially when many should easily be outliving us!”
Photo: www.depositphotos.com
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
The company says its Skinsights Learning Academies help support individuals and practices improve the healthcare outcomes for the 25% of dogs medicalised by skin problems in the UK.
A number of recognised industry professionals will be giving interactive, bite-sized talks at the events, including: Filippo De Bellis, Ian Wright, Jill Maddison, Sarah Warren, Rob Pope, Evelyn Maniski and Emily Robson as well as Zoetis veterinary and business consultants.
Zoetis says all the presentations will be highly practical, presented through case reviews, research, workshops and discussions. They will offer the latest information on game-changing therapeutics, best practice work-ups, effective protocols and insightful case-studies.
The sessions are limited to groups of 30 and Zoetis says places are expected to fill quickly.
To reserve your free place, visit: http://www.zoetis.co.uk/LVS2018
If you are unable to secure a seat in the theatre, headsets will be available on the day so you can listen to the lectures whilst on the stand.
Fort Dodge has unveiled an initiative to help practices improve peri-operative care and the management of hospitalised cases with the launch of its Early Warning Scoring System (EWSS) kit.
The kit contains cat and dog anaesthesia and observation charts for the effective monitoring of cats and dogs during operations, post-operatively and for hospitalised medical cases.
EWSS observation charts are widely used in the NHS but this is believed to be the first time that such a system has been developed specifically for use in veterinary practices.
They have been designed by Mike Davies BVetMed CertVR CertSAO FRCVS, Technical Services Manager at Fort Dodge, and are intended to help veterinary nurses and veterinary surgeons identify patients whose condition is deteriorating before they reach a critical state.
Mike Davies speaks around the country on preventive medicine and geriatrics and his experience of working closely with practices is that many do not have good protocols in place for nurse monitoring of patients. The EWSS grades parameters such as heart rate, respiratory rate, blood pressure and CNS response and the charts incorporate areas in which the practice can record pain using a visual analogue scale or a numeric scoring system.
The company has also launched Dorbene vet, a new product providing fast-acting sedation and analgesia for dogs and cats. Its active ingredient is the trusted and well proven alpha-2 agonist medetomidine hydrochloride, which affects the nervous system by inhibiting noradrenaline mediated neurotransmission. A dosing guide for Dorbene vet is also included in the EWSS.
The launch of Dorbene vet complements Fort Dodge's existing companion animal products, analgesic Torbugesic and dissociative anaesthetic Ketaset. Used alone it offers dose-related sedation within 10-15 minutes, which is rapidly reversible using the alpha-2 antagonist atipamezole for predictable recovery. It is presented in 10 ml and 50 ml multi dose vials in amber coloured glass which protects the product from light.
For further information on the EWSS or Dorbene vet, contact Fort Dodge on 01489 781711.
The results of the UK's first ever public National Equine Health Survey have quantified non-notifiable healthcare issues affecting horses, ponies, donkeys and mules in the UK.
The survey, which was pioneered by The Blue Cross animal charity and is supported by The British Equine Veterinary Association, was carried out last November following two years of pilot schemes. The intention was to find out more about endemic non-notifiable diseases that have never before been recorded in horses, ponies, donkeys and mules, such as coughs, skin diseases and lameness.
The results were announced at the National Equine Forum by Professor Josh Slater, Professor of Equine Clinical Studies at The Royal Veterinary College, who has been working with The Blue Cross on the survey.
A total of 306 sets of records were submitted from 3120 horses in mainly private ownership, with a balance of representation from competition yards, riding schools, welfare charities and studs. A broad range of syndromes and diseases were assessed including colic, sarcoids, laminitis, wounds, dental issues, eye disease, lameness and weight issues.
The results showed that lameness was the most common problem affecting horses (11% of horses surveyed) but that the foot was not the most common cause of lameness and that laminitis (3%) was less common than the 7-8% total that previous surveys had suggested.
Weight management was the next most common issue for horse owners, with 9% of horses recorded as overweight and 8% as underweight. These figures are lower than previous surveys which may be because they are based on the owner's assessment of their horse's weight which is subjective and may vary according to their perception of 'the right weight'.
Skin disease and wounds (5% and 4% respectively) posed a significant problem and colic (2%) was also a common occurrence, with a 6:1 ratio between medical and surgical cases.
The survey is breaking new ground in Europe as well as the UK. Currently Government agencies in all European countries conduct surveillance for prescribed exotic diseases such as West Nile Virus and African Horse Sickness but currently there are no large scale surveillance programmes for endemic diseases.
Professor Slater said: "The regular collection of such data holds numerous benefits to the UK equine industry. Not only does the survey provide a benchmarking facility for equine disease, welfare, standards of care and codes of practice but it will also underpin standards for yard inspection schemes. Not least it confirms the workability of an important template to monitor the serious threat of infectious and exotic disease in the future."
He added: "It's exciting to see hints in the NEHS 2010 survey that data 'straight from the horse's mouth' might challenge some established ideas. For example; the survey found that lameness was common, as you would expect, but that the foot was not the most common cause of lameness, which you might not have expected. This kind of data has never been collected before and is invaluable to the veterinary profession and wider animal welfare industry, helping to inform our future research, training and education. It will be really exciting to see the results of the larger surveys The Blue Cross are running in 2011."
Kerry Doyle, education officer at The Blue Cross said: "We are thrilled to be involved with this innovative project to enhance the future health of our horses and very grateful to all those who have participated in the survey so far. We now need even more horse owners to sign up for the next round so that we can capture as much useful data as possible."
The National Equine Health Survey is currently funded by The Blue Cross but sponsorship is being sought. It is to be conducted twice-yearly with the next census week planned for 9-15 May 2011. All keepers and owners of horses are urged to participate and details of all horse owners will remain anonymous. It's very quick and easy to complete and should only take around five minutes. To register online visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk.
Gerry, who joined North Downs in 2008, has been clinical director at the hospital since 2012.
He has published scientific literature and lectured across the world on a range of cancer subjects including lymphoma, mast cell tumours, lung tumours, insulin-producing tumours and novel anti-cancer therapies.
He also chairs and participates in a number of European oncology research projects and has a particular interest in collaborative clinical research.
Gerry said: “I’m delighted to be taking on this role, working alongside an incredibly talented and committed team.
“NDSR has achieved so much over the years, not only with cutting-edge treatments and procedures, but also with the implementation of an innovative new nursing structure, an industry-leading internship programme and being among the first veterinary hospitals to achieve a Green iiE award, to name just a few.
Talking about his main aims for the new role, Gerry said: “I want to create opportunities for our amazing team to develop into leadership roles, giving more autonomy to individual services and improving communication between services and management.
“From a care quality perspective, we always want to improve, and I look forward to harnessing innovative ideas and tools that might lead to better outcomes for pets and their families.
https://www.ndsr.co.uk.
VECCS was founded in 1974 to promote the advancement of knowledge and high standards of practice in veterinary emergency medicine and critical care.
To that end, it hosts a membership community, medical journal, monthly webinars, facility certification, wellness initiatives, a charitable arm and two annual educational conferences.
The two organisations are collaborating to raise awareness of Improve's Emergency Medicine and Surgery online learning programme.
Upon successful completion of the training and examinations, delegates can earn an ISVPS General Practitioner Certificate and a Postgraduate Certificate awarded by Harper Adams University.
Delegates cover 14 subjects and take part in three practical sessions under the guidance of specialists in preparation of real-life scenarios.
On completion, veterinary surgeons can earn 168 RACE-approved CE credits and also an ISVPS General Practitioner Certificate (GPCert) and Harper Adams Postgraduate Certificate (PgC).
Dr Charlotte French, Head of Business Development for the US at Improve Veterinary Education, said: “We are excited to partner with VECCS and to expand our global efforts in improving emergency medicine in practice.
"It is one of the most difficult areas that vets must tackle, so we are proud to be working together in building a strong foundation of knowledge so vets can approach these high-pressure situations with the right tools.”
improveinternational.com
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
"Great Workplaces: Raising the Bar (Elevating Skills, Culture, and Leadership)" is a series of four in-depth conversations that will tackle themes that have an impact on recruitment and retention, uncovered through the Great Workplaces by BVA accreditation scheme.
All members of the profession are welcome to join the 50-minute webinar, which will be hosted by Rob Williams, BVA President, and Dr. Kirsten Ronngren, ManyPets Consulting Veterinarian & Vet Engagement Lead.
Rob said: “Effective mentorship is the backbone of any thriving veterinary workplace.
"Whether you’re guiding others or building your own skills, strong mentoring relationships can make all the difference.
"We hope colleagues find the webinars engaging and informative. In our first session, we’ll explore the power of mentoring and work through common gaps revealed by the Great Workplaces by BVA accreditation scheme.”
https://mybva.bva.co.uk/ems-event-calendar/mentoring-matters.html
Dechra Veterinary Products is warning veterinary professionals it is experiencing supply issues with Oxyglobin, Haemoglobin Glutamer-200.
Dechra has supplied Oxyglobin under an exclusive UK distributor agreement with Biopure Corporation since 2002. In 2009, the assets of Biopure Corporation were acquired by OPK Biotech, which has its headquarters in Cambridge, MA, USA. OPK Biotech is working to resume manufacture of Oxyglobin as soon as possible but it is not expected this will happen until well into 2011.
Bob Parmenter, Managing Director of Dechra Veterinary Products, said: "Unfortunately we are now out of stock of Oxyglobin and, due to the supplier's manufacturing issues, we are unlikely to receive new supplies in the immediate future. I would like to apologise to veterinary professionals for any inconvenience this will cause to their practice but unfortunately this situation is out of our control. We have written to all our Oxyglobin customers to inform them of the position and will keep in contact to advise them when the situation has changed."
Dechra is advising veterinary professionals that the Pet Blood Bank may be able to offer an alternative product, while Oxyglobin is out of stock. The Pet Blood Bank can be contacted on 01509 232 222, Monday to Friday between 0830 and 1830. The organisation offers a same day and next day delivery service, along with an advice line. Full details of products and services are available by logging on to www.petbloodbank.org